Skip to main content
Cell therapy

Quell Therapeutics

Quell aims to develop engineered T regulatory (Treg) cell therapies

Quell aims to develop engineered T regulatory (Treg) cell therapies. Tregs are a subset of T cells that provide a regulatory function and have the ability to prevent unwanted over-activation of the immune system through their strong immune-suppressive capacity. Quell will seek to utilise the power of Treg cells to advance therapies for the management and treatment of a range of solid organ transplant and autoimmune conditions.